— XENITRA LIMITED
Growing the world’s best brands in Asia with authentic products and loyal customers
About Us
Xenitra Limited (ASX: XEN) connects premium Global FMCG Brands with high-growth Asian consumer markets.
Our growth strategy is based on two product-tailored sales channels: Pharmaceuticals and Web3 Commerce.
Explore More:
ABOUT – TWO CORE ASSETS
Xenitra is focused on two core assets:
Please click on the blocks below to view details…
International Medicines and healthcare products distributed to consumers in China.
01 – Pharmaceuticals
Pharmaceuticals division fully established and selling
Summary
International medicines and healthcare products distributed to consumers in China through platform wholesale, B2B supply to shopfronts and owned digital shopfronts.
Product Profile
OTC and prescription medicines, and Food for Special Medical Purposes (FSMP), from global pharmaceutical brand partners.
Margin Profile
20-40%
Future Focus
More approved SKUs with reliable replenishment, diversified suppliers and channels, and a strategic offtake partnership with JD Health (in negotiation).
JD Health – 3yr – Prescription Medicines
Kangsheng – 3yr – OTC Medicines
Pharma sales to date
JD Health customers
OTC medicines channel now operational
Hong Kong Fukang Trading Co. acquired (April 2026), enabling a fast start into the ecommerce channel with established sales, warehousing and team members experienced in cross-border OTC medicine sales in Greater China.
JD.com Storefront
An active OTC medicine shopfront on JD.com, China’s major B2C e-commerce platform, allowing an immediate and seamless commencement of sales.
Trademark and Warehouse infrastructure
Class 35 trademark registration plus warehouse logistics service, customer database, and on-hand inventory also acquired.
HK Pharma Licences established
Xenitra holds a Hong Kong pharmaceutical wholesale licence enabling cross-border OTC sales into China, plus OTC retail and prescription pharmaceutical licences.
$100m partnership: JD Health
A go-to-market strategy linking international suppliers through our Hong Kong operations to JD Health — China’s largest online healthcare platform.
Expanding Brand Partnerships
Product and brand portfolio includes Nestlé and Aptamil nutrition, Finacea, Naprogesic, Lixiana, Pien Tze Huang and HYLO.
Real world assets tied to smart contract framework for digitally engaged customers.
02 – Web3 Architecture
Web3 infrastructure — fully operational and in the market
Summary
End-to-end blockchain-enabled commerce and payment system, supported by authentication and a loyalty / rewards program driving customer willingness to pay.
Product Profile
FMCG products across all categories exclusive to Xenitra — piloted with EZZ Life Sciences and Biomiq.
Margin Profile
40-90 %
Future Focus
Rapidly expanding sales by onboarding new brands and increasing numbers of new distributor and end user customers.
Web3 Sales · Apr-Oct 2026
Total Participants
Distributors
Wholesalers
Web3 Commerce
Web3 Commerce is the future of eCommerce
End-to-end blockchain-enabled commerce and payments. Xenitra has created a highly scalable, fractionalised and globally accessible business — minting OPAL tokens, building the Web3-powered XEN Shop, onboarding a network of hundreds of distribution partners and establishing the legal frameworks and token reserve fund.
Web1
Read
Browse information published on websites
Web2
Interact
Shop, communicate and earn platform-managed rewards
Web3
Own & Transact
Hold tokens in a wallet for authentication and rewards, or trade and transfer them
Web3 Infrastructure combined with RWA
Xenitra has created a highly scalable, fractionalized and globally accessible business
ABOUT – BOARD & SENIOR MANAGEMENT

Bachelor of Information Technology and Master of Accounting
Tracy is the commercial leader of Xenitra globally and is an accomplished professional in the Fast-Moving Consumer Goods (FMCG) sector. Throughout her career she has developed exceptional expertise in brand management, ecommerce and commercial operations. She is the architect behind the Huibeijia brand in China, successfully establishing a thriving network of over 400 stores nationwide and since 2023 has spearheaded significant commercial expansion within the Xenitra Sales and Marketing ecosystems in the Chinese market and internationally.

Doctor of Philosophy, Master of Business Administration, Bachelor of Science
Anthony has extensive Board and management experience, including as CEO and Managing Director of Australian Biotherapeutics and The Calmer Co. Anthony worked for a decade building SFI-Health Group as Group Head of Innovation, Group Head of North Asia and was Managing Director of SFI-Research and SFI-Shineway (China). Anthony was part of the M&A team which acquired and integrated multiple companies including Flordis (Australia) Ginsana (Switzerland), Klaire Labs (USA), Prothera (USA), Complementary Prescriptions, (USA) and Potters (UK).
Anthony is Executive Director at Servatus Biopharmaceuticals Limited and leads their fast-growing Biomiq skincare brand.

Bachelor of Laws, Bachelor or Arts
Carl is an experienced board director with a strong background in governance, strategy, and commercial leadership. He brings a disciplined, outcomes focused approach to board oversight, informed by both senior commercial experience and a foundation in legal practice. In his legal career, Carl has advised clients across multiple sectors, working closely with executive teams on strategy formulation, business transformation, and growth initiatives.

Bachelor of Commerce, Chartered Accountant
Mr Grujic is an accomplished board member and senior finance executive with over 20 years’ experience across ASX-listed entities and high-growth organisations. A Chartered Accountant and Graduate of the Governance Institute, he has held senior leadership roles across a diverse range of sectors, including financial services, FMCG, transport, equity markets, NDIS, not-for-profit organisations and SaaS Technology.

Bachelor of Tourism Management
Alex Li is a Director of Xenitra Limited and a prominent Australia–China tourism and hospitality leader. A Tourism Australia–awarded Aussie Specialist China Ambassador, he is Founder and President of V-Tour Travel Service Zhejiang (a top-three AU/NZ outbound wholesaler in China) and Chairman or Co-Founder of multiple tourism, hospitality and travel businesses across both countries.